A novel Research has been published: "Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy"
July 3, 2019, 4:54 p.m.

College of Pharmacy at UoD is pleased to announce that a new novel research entitled "Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy" has been published, on 01 July 2019, in a well recognized "Journal of Maternal-Fetal & Neonatal" at "Taylor & Francis Group of Journals" registered in England and is a TR indexed journal with 1.5 Impact Factor.

A group of researchers: "Burhan Abdullah Zaman, Suzan Omer Rasool, Saja Mohammed Jasim & Deldar Morad Abdulah" came up with this new idea and worked for more than a year and half to establish a whole new novel biomarker to diagnose IDA in pregnant women.



Objectives: Hepcidin hormone production is suppressed in the case of iron deficiency. The role of hepcidin as a hormone in iron metabolism along with its diagnostic cut-off values and its sensitivity and specificity among pregnant women with iron deficiency anemia (IDA) was examined in this study.

Methods: In this case-control study, three groups of pregnant subjects were included according to the following criteria: cases/patient group: pregnant women with IDA based on, Hb < 11.5g/dl, S ferritin < 10ng/ml, TS%<15%; positive control group: pregnant women with non-IDA based on, Hb < 11.5g/dl, S ferritin > 10ng/ml, TS%>15%; and negative control group: included non-anemic apparently healthy pregnant women based on, Hb > 11.5g/dl, S ferritin > 10ng/ml, TS%>15%.

Results: The serum hepcidin was significantly lower in pregnant women with IDA (0.34ng/ml) compared to its level in pregnant women with non-IDA (23.48ng/l) and apparently healthy pregnant women (13.86ng/ml; p<.001). The study found a significant correlation between serum hepcidin and iron deficiency-related parameters with adjustment for study groups (p<.01). Moreover, the study found that serum hepcidin has good sensitivity in the range of 0.49–0.76ng/ml (80.6–83.3%) and good specificity (76.2%) over positive IDA. Similar results were found for serum hepcidin over negative control group (0.49–0.83ng/ml; sensitivity: 80.6–83.3%; specificity: 75.8–78.8%).

Conclusions: This study suggests that serum hepcidin is superior to hemoglobin, serum iron, serum ferritin, TS, and TIBC as an indicator of IDA in pregnant women.

Study register: 24012018-1 on 24 January 2018.


Direct link: